Combined CT Angiography, CT Perfusion Imaging and MACE Prediction
The combination of CT angiography and CT perfusion versus the combination of invasive coronary angiography plus single photo emission CT in predicting two-year MACE.
Using CT angiography and CT perfusion together provides similar results to invasive coronary angiography (ICA) plus single photon emission CT in predicting two-year major adverse cardiovascular events (MACE), late MACE, and event-free survival, according to a study published in Radiology.
Researchers from the United States, Brazil, Japan, Germany, the Netherlands, Singapore, Denmark, and Canada sought to compare the prognostic importance (time to MACE) of combined CT angiography and CT myocardial stress perfusion imaging with that of combined ICA and stress single photon emission CT myocardial perfusion imaging.
A total of 381 patients, aged 45 to 85, participated in the study. All were enrolled in the Combined Noninvasive Coronary Angiography and Myocardial Perfusion Imaging Using 320-Detector Row Computed Tomography (CORE320) prospective multicenter diagnostic study. Their images were analyzed in blinded independent core laboratories, and a panel of physicians adjudicated all adverse events.
MACE was defined as:
• Revascularization (more than 30 days after index ICA), myocardial infarction, or cardiac death
• Hospitalization for chest pain or congestive heart failure
• Arrhythmia
Late MACE was defined similarly, except for patients who underwent revascularization within the first 182 days after ICA, who were excluded.
The results showed that a MACE occurred in 51 of 379 patients (13.5%):
• 49 revascularizations
• Five myocardial infarctions
• One cardiac death
• Nine hospitalizations for chest pain or congestive heart failure
• One arrhythmia
The 2-year MACE-free rates were similar for combined CT angiography and CT perfusion findings to combined ICA and single photon emission CT findings:
Event-free rates for CT angiography and CT perfusion versus ICA and single photon emission CT for either positive or negative results were not significantly different for MACE or late MACE. The area under the receiver operating characteristic curve (AUC) for combined CT angiography and CT perfusion (AUC = 68) was similar to that for combined ICA and single photon emission CT (AUC = 7) in the identification of MACE at two-year follow-up.
The researchers concluded that combined CT angiography and CT perfusion enabled similar prediction of two-year MACE, late MACE, and event-free survival similar to that enabled by ICA and single photon emission CT.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
